Projects per year
Search results
-
Active
-
An Open-label, Multicenter Trial of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
Singh, M., Abdelrahim, M., Heyne, K., Niravath, P. A. & Zhang, J.
7/25/22 → …
Project: Clinical Trial
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
Satkunasivam, R., Butler, E. B., Chen, S., Esnaola, N. F., Farach, A. M., Teh, B. S. & Zhang, J.
1/20/22 → …
Project: Clinical Trial
-
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy
Zhang, J., Chan, E. Y., Gibbs, J. M., Heyne, K., Kim, M. P., Singh, M. & Sultenfuss, M. A.
9/16/21 → …
Project: Clinical Trial
-
-
Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma-CoImmune CMN-001-1
Satkunasivam, R., Singh, M. & Zhang, J.
8/26/21 → …
Project: Clinical Trial
-
INTEGRATION OF IMMUNOTHERAPY INTO ADJUVANT THERAPY FOR RESECTED NSCLC: ALCHEMIST CHEMO-IO (ACCIO)
Bernicker, E. H. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
Durvalumab vs Placebo Following Stereotactic Body Radiation Therapy in Early Stage Non-small Cell Lung Cancer Patients
Zhang, J., Haque, W. M., Heyne, K., Shadle, K. M. & Singh, M.
9/25/19 → …
Project: Clinical Trial
-
EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non¿Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature
Bernicker, E. H., Darcourt, J. & Zhang, J.
2/28/19 → 2/27/44
Project: Non Profit
-
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL
Arentz, C., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
12/8/16 → 12/7/41
Project: Non Profit
-
Not started
-
Circulating tumor DNA 5-hydroxymethylcytosine as a novel biomarker for cancers.
Li, Z., Bernicker, E. H., Chang, J. C., Darcourt, J., Pingali, S. R., Sahay, S., Shah, S., Singh, M., Zhang, J., Zhou, S. & Zu, Y.
Project: Clinical Trial
-
Phase Ib Trial of L-NMMA in Combination With Pembrolizumab in Patients With Melanoma, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Classical Hodgkin Lymphoma, Urothelial Carcinoma, or Microsatellite Instability-High/Mismatch Repair
Zhang, J., Heyne, K. & Singh, M.
Project: Clinical Trial
-